ELAB Stock Analysis: Buy, Sell, or Hold?
ELAB - PMGC Holdings Inc. Common Stock
$6.66
6.05 (991.80%)
▲
5d:
+631.87%
30d:
+601.87%
90d:
+301.2%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 18, 2026
0d
Get Alerted When ELAB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: ELAB is 528.3% above its trading range ($1.06). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: ELAB is 528.3% above its trading range ($1.06). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: ELAB is currently trading at $6.66, which is considered oversold relative to its 30-day fair value range of $0.82 to $1.06.
Technical Outlook: Technically, ELAB is in a downtrend. Immediate support is located at $0.54, while resistance sits at $7.29. The stock is showing strong short-term momentum, up 991.8% recently.
Market Sentiment: ELAB scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELAB is in a downtrend. Immediate support is located at $0.54, while resistance sits at $7.29. The stock is showing strong short-term momentum, up 991.8% recently.
Market Sentiment: ELAB scores 5/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.82 -
$1.06
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
58.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (5/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+991.8%)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.82 -
$1.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.54
Resistance Level
$7.29
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Revenue Growth (YoY)
-45.8%
Share & Embed Analysis
Last updated: August 23, 2026 9:08 AM ET
Data refreshes hourly during market hours. Next update: 10:08 AM
Data refreshes hourly during market hours. Next update: 10:08 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 50 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$127 | 41 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
10 analysts |
$138 | 66 BUY |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 50 HOLD |
|
SMMT
Summit Therapeutics PLC |
STRONG BUY
10 analysts |
$29 | 55 HOLD |
